Novozymes Boosts Microbiome with Biota Buy

Novozymes has acquired Biota’s microbiome R&D team and data science platform for an undisclosed sum. The move builds on two previous deals in the microbiome field this past year, notably of US-based Microbiome Labs and Ireland’s PrecisionBiotics.

“This acquisition fits well with our strategy, Better Business with Biology. Building on acquisitions we made last year within human health, we’re strengthening our expertise and capabilities within microbiomes, ensuring we extract as much value from these acquisitions as possible,” said Novozymes’ president and CEO Ester Baiget.

“Understanding micro-organisms and their role in shaping human, animal and plant health represents tremendous innovation opportunities for Novozymes,” added Claus Crone Fuglsang, Novozymes’ executive vice president and chief scientific officer.

Biota describes itself as a “pioneer of genomics for industrial markets.” Based in San Diego, California, USA, Biota said that by applying earth’s microbes as ubiquitous sensors, tracking devices or data libraries, it can improve the economics and greenhouse gas emissions of industrial processes in several large markets, such as energy, water and manufacturing.

Novozymes said that as well as advancing its ability to discover new beneficial microbes, the assets will also help prove the application performance of those microbes, for example through clinical trials where Biota’s expertise, data pipelines and artificial intelligence will accelerate and de-risk timelines.

Biota will retain a commercial license to apply the data science platform for genomic diagnostics.

Author: Elaine Burridge, Freelance Journalist

Novozymes has acquired Biota’s microbiome R&D team and data science platform...
Novozymes has acquired Biota’s microbiome R&D team and data science platform for an undisclosed sum. The Danish biotech said the assets will advance its ability to discover new beneficial microbes and accelerate and de-risk timelines of clinical trials. (c) Novozymes

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read